Stockreport

ARS Pharmaceuticals announces NMPA approval for neffy 2 mg [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF emergency treatment of Type 1 allergic reactions in adults and children who weigh 30 kg or more. ARS Pharma and Pediatrix Therapeutics anticipate filing for approval of [Read more]